Pasithea Therapeutics Corp. (KTTA)
NASDAQ·Healthcare·Biotechnology
$0.45
+0.00%
Mkt Cap $5.95M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+566.7%
Consensus $3.00 vs current $0.45
NASDAQ·Healthcare·Biotechnology
$0.45
+0.00%
Mkt Cap $5.95M
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+566.7%
Consensus $3.00 vs current $0.45